These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1107234)

  • 21. Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed-type hypersensitivity.
    Gaga M; Frew AJ; Varney VA; Kay AB
    J Immunol; 1991 Aug; 147(3):816-22. PubMed ID: 1830598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-specific and DNP--erythrocyte rosette formation after contact sensitization with DNCB.
    Scheper RJ; van Dinther-Janssen CH
    Immunology; 1975 Oct; 29(4):731-43. PubMed ID: 1102447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of a delayed hypersensitivity reaction to a contact allergen, by the systemic administration of interleukin-2.
    Zaloom Y; Walsh LP; McCulloch P; Gallagher G
    Immunology; 1991 Apr; 72(4):584-7. PubMed ID: 2037319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of the immune system in the mouse. 1. Drug administration prior to antigen sensitization.
    Cottney J; Bruin J; Lewis AJ
    Agents Actions; 1980 Sep; 10(4):378-88. PubMed ID: 7446316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential ability of occupational chemical contact and respiratory allergens to cause immediate and delayed dermal hypersensitivity reactions in mice.
    Dearman RJ; Mitchell JA; Basketter DA; Kimber I
    Int Arch Allergy Immunol; 1992; 97(4):315-21. PubMed ID: 1597352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene.
    Stricker RB; Goldberg B; Mills LB; Epstein WL
    J Am Acad Dermatol; 1995 Oct; 33(4):608-11. PubMed ID: 7673493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a Candida albicans delayed-type hypersensitivity (DTH) model in female juvenile rats for use in immunotoxicity assessments.
    Collinge M; Thorn M; Peachee V; White K
    J Immunotoxicol; 2013; 10(4):341-8. PubMed ID: 23282408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific suppression of delayed hypersensitivity skin reactions to collagen in guinea-pigs after immunization with collagen and Freund's incomplete adjuvant.
    Gentner GJ; Adelmann BC
    Immunology; 1976 Jul; 31(1):87-94. PubMed ID: 1027721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia.
    Ascher MS; Jahrling PB; Harrington DG; Kishimoto RA; McGann VG
    Clin Exp Immunol; 1980 Aug; 41(2):225-36. PubMed ID: 7438552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of the delayed-type hypersensitivity reaction by oxazaphosphorines.
    Turk JL
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):605-10. PubMed ID: 3325716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of suramin on the immune responses to sheep red blood cells in mice. I. In vivo studies.
    Brandely M; Lagrange P; Hurtrel B; Motta I; Truffa-Bachi P
    Cell Immunol; 1985 Jul; 93(2):280-91. PubMed ID: 3159481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immediate and delayed (late-phase) dermal contact sensitivity reactions in guinea pigs. Passive transfer by IgG1 antibodies, initiation by mast cell degranulation, and suppression by soybean proteinase inhibitor.
    Moore KG; Dannenberg AM
    Int Arch Allergy Immunol; 1993; 101(1):72-81. PubMed ID: 8499777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the sensitization of animals with simple chemical compounds. XII. The influence of excision of allergenic depots on onset of delayed hypersensitivity and tolerance.
    Macher E; Chase MW
    J Exp Med; 1969 Jan; 129(1):103-21. PubMed ID: 5782765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of delayed-type hypersensitivity reactions by cyclophosphamide-sensitive T cells.
    Schwartz A; Askenase PW; Gershon RK
    J Immunol; 1978 Oct; 121(4):1573-7. PubMed ID: 308970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of delayed-type hypersensitivity and cellular immunity to microbial vaccines: effects of cyclophosphamide on the immune response to tularemia vaccine.
    Ascher MS; Parker D; Turk JL
    Infect Immun; 1977 Nov; 18(2):318-23. PubMed ID: 924675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirement for a bacterial flora before mice generate cells capable of mediating the delayed hypersensitivity reaction to sheep red blood cells.
    MacDonald TT; Carter PB
    J Immunol; 1979 Jun; 122(6):2624-9. PubMed ID: 448137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Suppression of delayed hypersensitivity in mice receiving a massive dose of xenogeneic erythrocytes].
    Chernousov AD; Fontalin LN
    Biull Eksp Biol Med; 1979 Dec; 88(12):693-5. PubMed ID: 160253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elimination of immune suppressor mechanisms in humans by oxazaphosphorines.
    Berd D; Mastrangelo MJ
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):569-77. PubMed ID: 2963936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Building up of an animal model of conditioned immunosuppression and analysis of its possible mechanism].
    Li LQ; Wang JX; Song DM; Fan SG; Mei L
    Yao Xue Xue Bao; 1996; 31(6):477-80. PubMed ID: 9275727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [DNCB contact sensitization: theoretical and clinical aspects (author's transl)].
    Tönnesmann E; Bürkle PA; Federlin K
    Immun Infekt; 1977 Dec; 5(6):227-40. PubMed ID: 338472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.